A Comparative clinical study to evaluate the efficacy and safety of two Cystone formulations in patients suffering from Urolithiasis

The Himalaya Drug0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•?Subject with Urolithiasis as disgnosed by clinically as well as ultrasonographically with calculi measuring more than 5 mm.
•?Hematologic and Biochemical parameters within normal limits.
•? Willing to sign inform consent document

•?Those with serious cardiovascular, cerebrovascular, respiratory, liver or renal disease or any other disorder.
•?The subjects not to have used any drugs, for at least 1 week prior to the study.
•?Subjects with a strong history of food or drug allergy of any kind.
•?Subjects not to have been on weight reducing diets within 3 months prior to the start of the study.
•?No other drugs (including aspirin) to be ingested during the course of the study.
•?Patients unwilling to provide informed consent or abide by the requirements of the study

发起方

The Himalaya Drug